Literature DB >> 35298810

Dynamics of Amyloid Formation from Simplified Representation to Atomistic Simulations.

Phuong Hoang Nguyen1,2, Pierre Tufféry3, Philippe Derreumaux4,5.   

Abstract

Amyloid fibril formation is an intrinsic property of short peptides, non-disease proteins, and proteins associated with neurodegenerative diseases. Aggregates of the Aβ and tau proteins, the α-synuclein protein, and the prion protein are observed in the brain of Alzheimer's, Parkinson's, and prion disease patients, respectively. Due to the transient short-range and long-range interactions of all species and their high aggregation propensities, the conformational ensemble of these devastating proteins, the exception being for the monomeric prion protein, remains elusive by standard structural biology methods in bulk solution and in lipid membranes. To overcome these limitations, an increasing number of simulations using different sampling methods and protein models have been performed. In this chapter, we first review our main contributions to the field of amyloid protein simulations aimed at understanding the early aggregation steps of short linear amyloid peptides, the conformational ensemble of the Aβ40/42 dimers in bulk solution, and the stability of Aβ aggregates in lipid membrane models. Then we focus on our studies on the interactions of amyloid peptides/inhibitors to prevent aggregation, and long amyloid sequences, including new results on a monomeric tau construct.
© 2022. The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Aggregation; Amyloid; Aβ; Bulk solution; Inhibitors; Intrinsically disordered proteins; Membranes; Simulations; Tau; α-synuclein

Mesh:

Substances:

Year:  2022        PMID: 35298810     DOI: 10.1007/978-1-0716-1855-4_5

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  149 in total

Review 1.  Protein misfolding, evolution and disease.

Authors:  C M Dobson
Journal:  Trends Biochem Sci       Date:  1999-09       Impact factor: 13.807

2.  Is there a cause-and-effect relationship between alpha-synuclein fibrillization and Parkinson's disease?

Authors:  M S Goldberg; P T Lansbury
Journal:  Nat Cell Biol       Date:  2000-07       Impact factor: 28.824

Review 3.  α-Synuclein: membrane interactions and toxicity in Parkinson's disease.

Authors:  Pavan K Auluck; Gabriela Caraveo; Susan Lindquist
Journal:  Annu Rev Cell Dev Biol       Date:  2010       Impact factor: 13.827

4.  A soluble phosphorylated tau signature links tau, amyloid and the evolution of stages of dominantly inherited Alzheimer's disease.

Authors:  Nicolas R Barthélemy; Yan Li; Nelly Joseph-Mathurin; Brian A Gordon; Jason Hassenstab; Tammie L S Benzinger; Virginia Buckles; Anne M Fagan; Richard J Perrin; Alison M Goate; John C Morris; Celeste M Karch; Chengjie Xiong; Ricardo Allegri; Patricio Chrem Mendez; Sarah B Berman; Takeshi Ikeuchi; Hiroshi Mori; Hiroyuki Shimada; Mikio Shoji; Kazushi Suzuki; James Noble; Martin Farlow; Jasmeer Chhatwal; Neill R Graff-Radford; Stephen Salloway; Peter R Schofield; Colin L Masters; Ralph N Martins; Antoinette O'Connor; Nick C Fox; Johannes Levin; Mathias Jucker; Audrey Gabelle; Sylvain Lehmann; Chihiro Sato; Randall J Bateman; Eric McDade
Journal:  Nat Med       Date:  2020-03-11       Impact factor: 53.440

5.  NMR structure of the mouse prion protein domain PrP(121-231).

Authors:  R Riek; S Hornemann; G Wider; M Billeter; R Glockshuber; K Wüthrich
Journal:  Nature       Date:  1996-07-11       Impact factor: 49.962

Review 6.  The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics.

Authors:  John Hardy; Dennis J Selkoe
Journal:  Science       Date:  2002-07-19       Impact factor: 47.728

7.  Molecular structure of β-amyloid fibrils in Alzheimer's disease brain tissue.

Authors:  Jun-Xia Lu; Wei Qiang; Wai-Ming Yau; Charles D Schwieters; Stephen C Meredith; Robert Tycko
Journal:  Cell       Date:  2013-09-12       Impact factor: 41.582

Review 8.  Prions, prionoids and protein misfolding disorders.

Authors:  Claudia Scheckel; Adriano Aguzzi
Journal:  Nat Rev Genet       Date:  2018-07       Impact factor: 53.242

9.  Cryo-EM structures of tau filaments from Alzheimer's disease.

Authors:  Anthony W P Fitzpatrick; Benjamin Falcon; Shaoda He; Alexey G Murzin; Garib Murshudov; Holly J Garringer; R Anthony Crowther; Bernardino Ghetti; Michel Goedert; Sjors H W Scheres
Journal:  Nature       Date:  2017-07-05       Impact factor: 49.962

10.  Cryo-EM structure of alpha-synuclein fibrils.

Authors:  Ricardo Guerrero-Ferreira; Nicholas Mi Taylor; Daniel Mona; Philippe Ringler; Matthias E Lauer; Roland Riek; Markus Britschgi; Henning Stahlberg
Journal:  Elife       Date:  2018-07-03       Impact factor: 8.140

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.